LTGVV — Laboratório de Terapia Gênica e Vetores Virais

Publicações em destaque

Mais de 50 artigos em terapia gênica, AAV e neuroproteção

Indicadores bibliométricos

  • Publicações51
  • Citações1.579
  • Fator H15

Atualizado em 11/01/2026.

Ver todas no Google Scholar

  1. Clinical trials to gene therapy development and production in Brazil: a review

    Saute JAM, Picanço-Castro V, Petrs-Silva H, et al.

    The Lancet Regional Health — Americas·2025·6 citações

  2. rAAV-compatible human mini promoters enhance transgene expression in rat retinal ganglion cells

    Araujo VG, Dias MS, Hauswirth WW, Linden R, Petrs-Silva H

    Experimental Eye Research·2024

  3. The Healthy and Diseased Retina Seen through Neuron-Glia Interactions

    Tempone MH, et al. (incl. Petrs-Silva H)

    International Journal of Molecular Sciences·2024·12 citações

  4. Neuroprotective Gene Therapy by Overexpression of the Transcription Factor MAX in Rat Models of Glaucomatous Neurodegeneration

    Lani-Louzada R, Marra C, Dias MS, et al. Petrs-Silva H, Linden R

    Investigative Ophthalmology & Visual Science·2022·16 citações

  5. The Role of Axonal Transport in Glaucoma

    Dias MS, Luo X, Ribas VT, Petrs-Silva H, Koch JC

    International Journal of Molecular Sciences·2022·31 citações

  6. Mitotherapy: Unraveling a Promising Treatment for Disorders of the Central Nervous System and Other Systemic Conditions

    Nascimento-dos-Santos G, De-Souza-Ferreira E, Linden R, Galina A, Petrs-Silva H

    Cells·2021·30 citações

  7. Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina

    Nascimento-dos-Santos G, De-Souza-Ferreira E, Lani R, et al. Petrs-Silva H

    BBA — Molecular Basis of Disease·2020·54 citações

  8. High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors

    Petrs-Silva H, Dinculescu A, Li Q, et al. Hauswirth WW

    Molecular Therapy·2008·332 citações